Juan Carlos Limachi, MD

There was once time The Kidney.

[Colegio de Nefrólogos de México A.C. @DeNefrologos]

¡Actualízate en nefroprotección! 🩺✨

Acompáñanos para analizar lo último en iSGLT2, GLP-1 y Finerenona.

🗓 20 de mayo | 19:00 h. 🎓 1 punto de valor curricular (CMN).
✅ Regístrate o inicia sesión aquí:🔗 https://t.co/na3328NOeV

#Nefrología #SaludRenal #Webinar #CNM

[Jonathan Chávez @JonathanNefro]

La protección que ofrecen los iSGLT2 sobre la litiasis renal, no es por la diuresis osmótica; tampoco por el incremento, momentáneo, de la ingesta de agua; ni por el reordenamiento osmótico. Se explica mejor por ↓ los índices litogénico

CKJ 2026
https://t.co/vveVp729st

[Dr.Marlon Villanueva™ 🩺 𝕏 @MarlonVFZR]

🫁𝗥𝘂𝗶𝗱𝗼𝘀 𝗿𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝗶𝗼𝘀 𝗮𝗱𝘃𝗲𝗻𝘁𝗶𝗰𝗶𝗼𝘀🌬️
⬇️⬇️⬇️⬇️

💧 𝘾𝙧𝙚𝙥𝙞𝙩𝙖𝙣𝙩𝙚𝙨 (𝙘𝙧𝙖𝙘𝙠𝙡𝙚𝙨)
➡️ líquido / fibrosis alveolar 🌫️
📌 neumonía • edema pulmonar • ILD

🎶 𝙎𝙞𝙗𝙞𝙡𝙖𝙣𝙘𝙞𝙖𝙨 (𝙬𝙝𝙚𝙚𝙯𝙞𝙣𝙜)
➡️ broncoconstricción 🔥
📌 asma • EPOC

🌊 𝙍𝙤𝙣𝙘𝙤𝙨 (𝙧𝙝𝙤𝙣𝙘𝙝𝙞)
➡️ moco en vía aérea grande 🧫
📌 bronquitis
💡 desaparecen con tos 🤧

🚨 𝙀𝙨𝙩𝙧𝙞𝙙𝙤𝙧 (𝙨𝙩𝙧𝙞𝙙𝙤𝙧)
➡️ obstrucción vía aérea alta 🛑
📌 cuerpo extraño • laringitis • edema glótico

🪵 𝙍𝙤𝙘𝙚 𝙥𝙡𝙚𝙪𝙧𝙖𝙡
➡️ pleura inflamada ⚡
📌 pleuritis
💡 no cambia con tos

🎯 𝘾𝙡𝙖𝙫𝙚 𝙘𝙡𝙞́𝙣𝙞𝙘𝙖
👉 localización + tono + respuesta a tos = diagnóstico 🧭

👇🏼👇🏼👇🏼👇🏼
📚📖#ClubCrit

#Respiratory #MedTwitter #CritCare #UCI #ICU #CriticalCare #Diagnóstico #icu #intensivecare #diagnosis #management #POCUS #MedicinaBasadaEnEvidencia #Terapia #MedEd #Medicina #FOAMed #FOAMcc #CuidadoCrítico #MedX #EducaciónMédica #MedIntensiva #MedXCommunity #MedicinaCrítica #MedED #CritCare #ICUManagement #MustRead #LecturaRecomendada

[KIReports @KIReports]

Sodium-Glucose Cotransporter-2 Inhibitors #SGLT2i and #Cardiorenal Events in #Nonalbuminuric Kidney Disease

#VisualAbstract by @acssjr

https://t.co/hWzul95OsF

@cwhuang0824

[Jasmine Sethi @JasmineNephro]

🫘👍Combination therapy in CKD

https://t.co/l8PwgWJHst

@NDTsocial @hjanders_hans

[Jonathan Chávez @JonathanNefro]

En diálisis, espironolactona o eplerrenona no mostraron ningún beneficio en mortalidad, pero ↑50% el riesgo de hiperkalemia severa

¿Pasaría lo mismo con finerenona ?🧐

The Lancet 2025
https://t.co/OwOH9TQ5kX

[Ahmed Bennis MD 🫀 @drbennisahmed]

Hyperkalemia in Heart Failure with Reduced Ejection Fraction: Implications and Management

This review emphasizes the importance of regular potassium monitoring, the potential benefits of combining therapies such as SGLT2 inhibitors with RAASi to reduce the risk of hyperkalemia, and the emergence nsMRA, finerenone, which may have a lower risk of hyperkalemia.

@mvaduganathan @gcfmd @SJGreene_md @AndrewJSauer @ankeetbhatt @BiykemB @ShelleyZieroth @DrMarthaGulati @hvanspall @HFA_President @hfcollaboratory

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

The latest 2025 #Hypertension Guidelines are out 📣
#Nephpearls

📌 Use of risk-based thresholds for initiation of BP treatment

📌 BP thresholds and recommendations for treatment and follow-up

📌 Screening for features suggesting secondary hypertension

👉🏼 https://t.co/CT6A2Ltkq0

[Jonathan Chávez @JonathanNefro]

Nos entusiasma observar ver que The American Society of Nephrology haya considerado nuestro Artículo y resaltarlo en “In The Loop”😃

Léanlo gratis
Kidney Medicine 2025
@KidneyMed

https://t.co/Jv92wYxbhr

[Maria José Fortuny @DoctoraFortuny]

📌 💙Review muy completo de tratamiento diurético en #insuficienciacardiaca aguda ¡Imprescindible para #Urgencias! ¡Enhorabuena @Begoef! 👏🏽👏🏽#DocenciaUrgencias https://t.co/uAqX5a3fJ1

[S.E.N. Nefrología @SENefrologia]

📣📣Publicado en 2025:
📍Guía de práctica clínica sobre detección y manejo de la Enfermedad Renal Diabética: documento de consenso #Geendiab
🇬🇧🇺🇸Read the Guideline in English: Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology https://t.co/2M7zP9rX1F

[AJPC @AJPCardio]

📰 New in AJPC: State-of-the-Art Review on Preeclampsia—exploring pathophysiological mechanisms and preventive strategies for better maternal heart health.

Read it here 👉 https://t.co/IdF0fSR6Ek

#PreventiveCardiology #Preeclampsia #WomenHeartHealth #AJPC #CardiologyResearch

[S.E.N. Nefrología @SENefrologia]

🤷‍♀️¿Conoces tus ABCDEs?
🔴A Albuminuria -Análisis orina
🟡B Blood Pressure -Presión arterial
🟢C Colesterol -Análisis sangre
🔵D Diabetes Mellitus -Análisis sangre
🟠E Estimated Glomerular Filtration Rate -Tasa filtración glomerular est. -Análisis sangre 👇#StrongKidneys @ERAkidney @torra_roser

[Int Society of Nephrology @ISNkidneycare]

🚨 Cardiorenal Syndrome (CRS): A Deadly Duo 🚨
Did you know the heart & kidneys are so intertwined that dysfunction in one can wreak havoc on the other?
Let's dive into CRS today.
A lucid read for every nephrology & cardiology fellow 🫀🩺
#MedTwitter
#ISNTweetorial

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

A home-based intervention improves participants’ activation in their own health and health care, and it may reduce risk factors for CKD in a rural disadvantaged population
#BestofCJASN #KidneyWk #Nephpearls
👉🏼 https://t.co/cZN0WioOE4

[GlomCon Ibero-LatinoAmérica @GlomConILA]

‼️No te pierdas este sábado el seminario:

☞ Potasio, termodinámica y el origen de la vida 🧬

🗓️ 21/Junio/25
🕘 9 am CDMX
👨🏻‍⚕️Dr. Tommaso Bochicchio 🇲🇽

Zoom ID: 863 6358 3637
Pass: 343 190

#GlomConILA #GlomConAmor #MeGusta

[Ahmed Bennis MD 🫀 @drbennisahmed]

SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application

CREDENCE, DAPA-CKD, EMPA-KIDNEY, and FLOW, have demonstrated their efficacy in preserving kidney function and reducing adverse outcomes

https://t.co/5gHJPCpGyL

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

CONFIDENCE: Finerenone with Empagliflozin in CKD and T2D
#ERA25 🇦🇹 #Nephpearls

📌 Among persons with both CKD and T2D, initial therapy with finerenone plus empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio (UACR) than either treatment alone 📷

👉 https://t.co/5Awq3CF1po

[Aranza Joffre @aranzajoffre]

✅Terapias de reemplazo renal continuas: Core curriculum 2025 🫘🙌🏼⏱️
American Journal of Kidney Diseases
DOI: 10.1053/j.ajkd.2024.09.015

Ventajas vs desventajas, principios físicos, modalidades, prescripción y mantenimiento. ✨ #AJKD #CRRT

[Jasmine Sethi @JasmineNephro]

🦋🫘Kidney Disease in Lupus Nephritis

https://t.co/1BGancAr6t

@AJKDonline